Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02829047 · ClinicalTrials.gov registry record · NA
Tolerability, Safety and Efficacy of a New Frequency of Vibrant Capsule Administration
A NA study, sponsored by Vibrant.
- Terminated
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT02829047: Clinical Trial NA study, sponsored by Vibrant.
NCT02829047 is a NA study that was terminated before completion, run by Vibrant. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02829047, a NA study, was terminated before completion, sponsored by Vibrant.
- TERMINATED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The study is a prospective, multicenter, open-label, single-arm study, to evaluate the tolerability, safety and efficacy of the Vibrant Capsule in relieving constipation.
Primary Outcome
Defined as the number of subjects with an increase from the run-in period of at least one weekly Spontaneous Bowel Movement (SBM) during at least 3 of the 6 weeks of treatment. Subjects with less than 2 weeks (with at least 5 days per week) of valid diary during the treatment period will be considered as non-evaluable.
Interventions
- DEVICE Vibrating Capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-03 |
| Phase | NA |
Why NCT02829047 stopped before completion
NCT02829047 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Vibrating Capsule is the first listed.
NCT02829047 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02829047 about?
NCT02829047 is a clinical study titled "Tolerability, Safety and Efficacy of a New Frequency of Vibrant Capsule Administration". The study is a prospective, multicenter, open-label, single-arm study, to evaluate the tolerability, safety and efficacy of the Vibrant Capsule in relieving constipation.
What is the current status of trial NCT02829047?
This trial is currently terminated. It is a NA study. The enrollment target is 25 participants. The study started on 2016-08. Estimated completion is 2017-03.
What interventions are being tested in trial NCT02829047?
The interventions under investigation include: Vibrating Capsule (DEVICE).
Who is sponsoring clinical trial NCT02829047?
This trial is sponsored by Vibrant, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02829047's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia